The clinical support is robust
Meg Tirrell 00:05:30 'Well, I think this is so interesting because a lot of those things people thought were just completely related to weight loss, you know, hey, if you lose 20% of your body weight, of course you're going to have a lower risk of having a heart attack or a stroke
GLP-1 medications are technically called GLP-1 receptor agonist medications
New England Journal Of Medicine *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, those on semaglutide lost on average 14.9% of their weight as opposed to 2% of the placebo group
But in the complicated world of drug pricing, Novos move to cut 35% to 50% off the list price of its semaglutide products, Ozempic, Rybelus, and Wegovy, to $675 a month may not mean many more payers will cover the drugs, which would allow more people to get them